Table 1.
Characteristics of the Study Population Number and Row Percentage of Characteristics by Statin Adherence Among People with Type 2 Diabetes and Dyslipidemia
| Total | Adequate Adherence PDC ≥0.8 | Poor Adherence PDC<0.8 | P-value | Sig. | |||||
|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | Chi-Square Value | |||
| 1532 | 100.0 | 1186 | 77.4 | 346 | 22.6 | ||||
| Age Mean (SD) | 58.8 (10) | 58.9(10) | 58.0(10) | ||||||
| LDL Mean (SD) | 2.6 (0.89) | 2.5(0.8) | 2.6(0.9) | ||||||
| Age Group | 3.81 | 0.28 | |||||||
| 18–44 | 106 | 6.9 | 77 | 72.6 | 29 | 27.4 | |||
| 45–54 | 397 | 25.9 | 298 | 75.1 | 99 | 24.9 | |||
| 55–64 | 646 | 42.2 | 510 | 78.9 | 136 | 21.1 | |||
| ≤65 | 383 | 25.0 | 301 | 78.6 | 82 | 21.4 | |||
| Gender | 14.29 | 0.00 | *** | ||||||
| Men | 443 | 28.9 | 371 | 83.7 | 72 | 16.3 | |||
| Women | 1089 | 71.1 | 815 | 74.8 | 274 | 25.2 | |||
| Marital Status | 2.80 | 0.09 | |||||||
| Single | 107 | 7.6 | 90 | 84.1 | 17 | 15.9 | |||
| Married | 1297 | 92.4 | 1000 | 77.1 | 297 | 22.9 | |||
| Nationality | 1.59 | 0.21 | |||||||
| Saudi | 1397 | 91.4 | 1076 | 77 | 321 | 23 | |||
| Non-Saudi | 132 | 8.6 | 108 | 81.8 | 24 | 18.2 | |||
| Hypertension | 0.70 | 0.40 | |||||||
| Yes | 1051 | 68.6 | 820 | 78 | 231 | 22 | |||
| No | 481 | 31.4 | 366 | 76.1 | 115 | 23.9 | |||
| Asthma | 0.65 | 0.42 | |||||||
| Yes | 134 | 8.7 | 100 | 74.6 | 34 | 25.4 | |||
| No | 1398 | 91.3 | 1086 | 77.7 | 312 | 22.3 | |||
| Osteoarthritis | 0.32 | 0.57 | |||||||
| Yes | 109 | 7.1 | 82 | 75.2 | 27 | 24.8 | |||
| No | 1423 | 92.9 | 1104 | 77.6 | 319 | 22.4 | |||
| Osteoporosis | 0.04 | 0.84 | |||||||
| Yes | 65 | 4.2 | 51 | 78.5 | 14 | 21.5 | |||
| No | 1467 | 95.8 | 1135 | 77.4 | 332 | 22.6 | |||
| Anxiety | 3.15 | 0.08 | |||||||
| Yes | 63 | 4.1 | 43 | 68.3 | 20 | 31.7 | |||
| No | 1469 | 95.9 | 1143 | 77.8 | 326 | 22.2 | |||
| Depression | 3.98 | 0.05 | * | ||||||
| Yes | 29 | 1.9 | 18 | 62.1 | 11 | 37.9 | |||
| No | 1503 | 98.1 | 1168 | 77.7 | 335 | 22.3 | |||
| Polypharmacy | 6.08 | 0.02 | * | ||||||
| ≥5 | 1116 | 72.8 | 846 | 75.8 | 270 | 24.2 | |||
| 0 to 4 drugs | 416 | 27.2 | 340 | 81.7 | 76 | 18.3 | |||
| LDL goal attainment | 0.002 | 0.964 | |||||||
| <100 | 636 | 41.5 | 492 | 77.4 | 144 | 22.6 | |||
| ≥ 100 | 896 | 58.5 | 694 | 77.5 | 202 | 22.5 | |||
Notes: Study population comprised of 1532 People with type 2 diabetes and dyslipidemia (age ≥18year) who visited outpatient’s clinics from a tertiary hospital. Polypharmacy was defined as the use of five or more medications. Asterisks (*) represent significant differences in statin adherence from chi-square tests and Fisher’s exact tests. ***P< 0.001; *0.01 ≤ p < 0.05
Abbreviations: LDL, low density lipoprotein level; PDC, Proportion of Days Covered; SD, Standard Deviation; Sig, Significance.